Brief: Novabay Pharmaceuticals Engages Financial Advisor Should Stockholders Fail To Approve Dissolution Proposal
07/03/2025 11:58
March 7 (Reuters) - NovaBay Pharmaceuticals Inc NBY.A: NOVABAY PHARMACEUTICALS INC: ENGAGES FINANCIAL ADVISOR TO EXPLORE STRATEGIC OPTIONS SHOULD STOCKHOLDERS FAIL TO APPROVE DISSOLUTION PROPOSAL NOVABAY PHARMACEUTICALS INC: STOCKHOLDERS AS OF MARCH 18, 2025 RECORD DATE WILL BE ENTITLED TO VOTE Source text: ID:nBwb3JRSa Further company coverage: NBY.A ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Stablecoin Development
See all newsBrief: Stablecoin Development Corporation Reports First Quarter 2026 Financial Results
Brief: Tether Says Participated In A $134 Million Financing Round For Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Announces Name Change To Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Says David Lazar Resigns As CEO
Brief: NovaBay Pharmaceuticals Files For Mixed Shelf Of Up To $200 Million - SEC Filing